ID LN-443 AC CVCL_3960 SY LN 443; LN443 DR BTO; BTO_0004449 DR BioGRID_ORCS_Cell_line; 407 DR BioSample; SAMN03151823 DR BioSample; SAMN10988388 DR cancercelllines; CVCL_3960 DR Cell_Model_Passport; SIDM01371 DR Cosmic; 849871 DR Cosmic; 2367496 DR Cosmic; 2516031 DR DepMap; ACH-000673 DR PharmacoDB; LN443_847_2019 DR Wikidata; Q54902784 RX PubMed=7693337; RX PubMed=8509230; RX PubMed=10416987; RX PubMed=20593219; RX PubMed=22570425; RX PubMed=25984343; RX PubMed=30894373; RX PubMed=31068700; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx CC Problematic cell line: Contaminated. Shown to be a LN-444 derivative (PubMed=22570425). Originally thought to originate from a 66 year old male patient with a glioblastoma at the right fronto-temporal lobe. CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00451. CC Population: Caucasian. CC Doubling time: 40 hours (PubMed=25984343). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His214Arg (c.641A>G); ClinVar=VCV000376615; Zygosity=Homozygous (DepMap=ACH-000673). CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; shRNA library screening. CC Genome ancestry: African=3.39%; Native American=0%; East Asian, North=4.23%; East Asian, South=0%; South Asian=4.37%; European, North=27.1%; European, South=60.91% (PubMed=30894373). CC Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802. ST Source(s): PubMed=22570425 ST Amelogenin: X ST CSF1PO: 10,12 ST D13S317: 8 ST D16S539: 10,11 ST D18S51: 15,16 ST D21S11: 28,30 ST D3S1358: 15,17 ST D5S818: 9,12 ST D7S820: 10 ST D8S1179: 13,14 ST FGA: 21,23 ST Penta D: 11,12 ST Penta E: 7,13 ST TH01: 7,9 ST TPOX: 8 ST vWA: 18,19 DI NCIt; C3058; Glioblastoma DI ORDO; Orphanet_360; Glioblastoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_3961 ! LN-444 SX Female AG 48Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 30 // RX PubMed=10416987; DOI=10.1111/j.1750-3639.1999.tb00536.x; PMCID=PMC8098486; RA Ishii, Nobuaki RA Maier, Daniel RA Merlo, Adrian RA Tada, Mitsuhiro RA Sawamura, Yutaka RA Diserens, Annie-Claire RA Van Meir, Erwin G. RT "Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor RT suppressor genes in human glioma cell lines."; RL Brain Pathol. 9:469-479(1999). // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). // RX PubMed=22570425; DOI=10.1093/neuonc/nos072; PMCID=PMC3367844; RA Bady, Pierre RA Diserens, Annie-Claire RA Castella, Vincent RA Kalt, Stefanie RA Heinimann, Karl RA Hamou, Marie-France RA Delorenzi, Mauro RA Hegi, Monika E. RT "DNA fingerprinting of glioma cell lines and considerations on RT similarity measurements."; RL Neuro-oncol. 14:701-711(2012). // RX PubMed=7693337; RA Li, Hong RA Hamou, Marie-France RA de Tribolet, Nicolas RA Jaufeerally, Rebana RA Hofmann, Martin RA Diserens, Annie-Claire RA Van Meir, Erwin G. RT "Variant CD44 adhesion molecules are expressed in human brain RT metastases but not in glioblastomas."; RL Cancer Res. 53:5345-5349(1993). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=25984343; DOI=10.1038/sdata.2014.35; PMCID=PMC4432652; RA Cowley, Glenn S. RA Weir, Barbara A. RA Vazquez, Francisca RA Tamayo, Pablo RA Scott, Justine A. RA Rusin, Scott RA East-Seletsky, Alexandra RA Ali, Levi D. RA Gerath, William F.J. RA Pantel, Sarah E. RA Lizotte, Patrick Hall RA Jiang, Guo-Zhi RA Hsiao, Jessica RA Tsherniak, Aviad RA Dwinell, Elizabeth RA Aoyama, Simon RA Okamoto, Michael RA Harrington, William RA Gelfand, Ellen T. RA Green, Thomas M. RA Tomko, Mark J. RA Gopal, Shuba RA Wong, Terence C. RA Li, Hu-Bo RA Howell, Sara RA Stransky, Nicolas RA Liefeld, Ted RA Jang, Dongkeun RA Bistline, Jonathan RA Meyers, Barbara Hill RA Armstrong, Scott Allen RA Anderson, Kenneth Carl RA Stegmaier, Kimberly RA Reich, Michael RA Pellman, David RA Boehm, Jesse S. RA Mesirov, Jill P. RA Golub, Todd Robert RA Root, David E. RA Hahn, William Chun RT "Parallel genome-scale loss of function screens in 216 cancer cell RT lines for the identification of context-specific genetic RT dependencies."; RL Sci. Data 1:140035.1-140035.12(2014). // RX PubMed=8509230; DOI=10.1002/ijc.2910540329; RA Rimoldi, Donata RA Romero, Pedro RA Carrel, Stefan RT "The human melanoma antigen-encoding gene, MAGE-1, is expressed by RT other tumour cells of neuroectodermal origin such as glioblastomas and RT neuroblastomas."; RL Int. J. Cancer 54:527-528(1993). // RX PubMed=20593219; DOI=10.1007/s11060-010-0283-9; RA Blough, Michael D. RA Beauchamp, Desiree C. RA Westgate, Morgan R. RA Kelly, John J.P. RA Cairncross, J. Gregory RT "Effect of aberrant p53 function on temozolomide sensitivity of glioma RT cell lines and brain tumor initiating cells from glioblastoma."; RL J. Neurooncol. 102:1-7(2011). //